US scientists find potential therapy for Ebola virus infection

December 12, 2017

Scientists from SRI International and Collaborations Pharmaceuticals in the US have identified a potential new inhibitor, tilorone dihydrochloride, for infection by Ebola virus. The researchers used machine learning methods to find the immunomodulatory drug, which is reported to have demonstrated significant efficacy with 100% survival in a disease model of the virus.